Allergy medication efficacy in adults
Pro Research Analysisby 
Searched over 200M research papers
Allergy Medication Efficacy in Adults: Overview and Key Findings
Allergic Rhinitis and Asthma: Burden and Medication Use
Allergic rhinitis and asthma are common conditions in adults, significantly affecting quality of life, sleep, and productivity. Most adults with allergic rhinitis rely on medications, but many report incomplete relief, slow onset, and reduced efficacy over time. Adverse effects such as drowsiness and unpleasant sensations are also common, leading to dissatisfaction and frequent changes in medication regimens. A notable proportion of adults experience little to no relief from current allergy medications, highlighting ongoing challenges in effective management .
Efficacy of Pharmacotherapies for Allergic Rhinitis
Meta-analyses show that all major allergy medications provide significant improvement in nasal symptoms compared to placebo. Among these, intranasal corticosteroids (INCS) are the most effective, followed by combination intranasal antihistamine/INCS, intranasal antihistamines, oral antihistamines, sublingual immunotherapy tablets (SLIT-tablets), and montelukast. For both seasonal and perennial allergic rhinitis, INCS consistently show the greatest reduction in symptom scores. However, direct comparisons between medication classes are limited due to differences in study designs and potential publication bias Meltzer2021Sousa-Pinto2024.
Sublingual Immunotherapy Tablets (SLIT) for Allergic Rhinitis and Asthma
SLIT-tablets targeting specific allergens (such as grass, ragweed, tree pollen, and house dust mite) are effective in reducing symptoms in both monosensitized and polysensitized adults. Improvements in symptom and medication scores are seen across different allergens, with similar safety profiles regardless of the number of allergens a patient is sensitive to . For house dust mite allergy, SLIT-tablets also reduce the risk of moderate or severe asthma exacerbations in adults with allergic asthma, especially during periods when inhaled corticosteroids are reduced or withdrawn. Most adverse events are mild and localized, such as oral itching or throat irritation Virchow2016Bergmann2016Nolte2013.
Intranasal Medications: Comparative Efficacy and Safety
Network meta-analyses confirm that intranasal antihistamines, corticosteroids, and their combinations are effective and safe for treating allergic rhinitis in adults. Fixed combinations of intranasal antihistamines and corticosteroids may offer additional benefits over single agents, providing more comprehensive symptom control .
Long-Term Effectiveness of Biologic Therapies
For adults with moderate-to-severe allergic asthma not adequately controlled by standard therapies, biologic agents like omalizumab have demonstrated long-term effectiveness and safety. Omalizumab reduces asthma exacerbations, improves lung function and quality of life, and decreases the need for corticosteroids, with benefits sustained for up to nine years in adults .
Conclusion
In adults, allergy medications—including intranasal corticosteroids, antihistamines, SLIT-tablets, and biologic therapies—are effective in reducing symptoms of allergic rhinitis and asthma. Intranasal corticosteroids generally provide the greatest symptom relief, while SLIT-tablets and biologics offer additional options for those with more severe or persistent symptoms. Despite these advances, a significant number of adults still experience incomplete relief and bothersome side effects, indicating a need for continued improvement in allergy management strategies Meltzer2012Meltzer2021Virchow2016+5 MORE.
Sources and full results
Most relevant research papers on this topic
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys.
The burden of allergic rhinitis has been substantially underestimated, with 14% of U.S. adults having it, and medication relief often insufficient and causing dissatisfaction.
Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and children.
All treatments significantly improved nasal symptoms compared to placebo, with sublingual immunotherapy tablets providing improvement despite access to rescue symptom-relieving pharmacotherapy.
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
The house dust mite sublingual allergen immunotherapy tablet significantly reduces the risk of asthma exacerbations during an inhaled corticosteroid reduction period.
Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
Ragweed allergy immunotherapy tablets (6 or 12 Amb a 1 units) are effective and well-tolerated in North American adults with ragweed allergy.
DOI